Central venous catheters inserted percutaneously via the femoral vein can be used long-term in recipients of allogeneic peripheral blood stem cell transplants

Rabitsch, Werner; Kalhs, Peter; Herold, Christina; Jaeger, U.; Greinix, HT

doi:10.1038/sj.bmt.1701833

Cited by 1 publication

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is another report on 1 adult patient who received high-dose chemotherapy and allogeneic peripheral blood stem cell transplantation via a femoral Hickman catheter for recurrence of high-grade nonHodgkin's lymphoma; this catheter was successfully used for 3 months and then had to be removed because of Staphylococcus epidermidis bacteremia. 11 In contrast to these reports from adult patients, to the best of our knowledge very few pediatric cancer patients with tunneled femoral central venous catheters have been reported to date. 4 Therefore, complication rates can only be compared with lines placed by conventional routes.…”

Section: Discussioncontrasting

confidence: 39%

Tunneled Femoral Central Venous Catheters in Children With Cancer

et al. 2001

View full text Add to dashboard Cite

ABSTRACT. Objective. We discuss the feasibility of long-term femoral venous access by means of a cuffed subcutaneously tunneled central venous catheter (Broviac catheter) in selected pediatric cancer and stem cell transplant patients in whom access via the veins of the upper part of the torso is difficult or contraindicated and in whom alternative routes must be used.Patients and Methods. We report on our experience with 9 patients (3 of whom underwent stem cell transplantation) who received femoral Broviac catheters between December 1990 and November 1999.Results. Time in place ranged from 4 to 155 days with a median of 58 days (mean: 71.2 days). Three catheters had to be removed: 1 because of infection of the subcutaneous tunnel and 2 because of catheter obstruction. The remaining 6 catheters functioned well without problems as long as they were needed; 1 of them got accidentally dislodged while the patient was off treatment. No episodes of catheter-related septicemia, thrombosis, kinking, or drug extravasation were noted; there were no catheter-related infectious complications in the transplant patients.Conclusions. Our experience indicates that in those instances in which customary access to the superior vena cava is precluded, long-term venous access by way of the femoral vein is a feasible and safe alternative in children, even in the setting of stem cell transplantation. Pediatrics 2001;107(6). URL: http://www.pediatrics.org/cgi/content/ full/107/6/e104; femoral long-term central venous catheters, Broviac, pediatric cancer patients.

show abstract

Section: Discussioncontrasting

confidence: 39%